These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8937104)

  • 21. In vivo measurement of iridial circulation using laser speckle phenomenon.
    Tomidokoro A; Araie M; Tamaki Y; Tomita K
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):364-71. PubMed ID: 9477995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation.
    Vuori ML; Ali-Melkkilä T; Kaila T; Iisalo E; Saari KM
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):682-5. PubMed ID: 7906474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of betaxolol on the retinal circulation in eyes with ocular hypertension: a pilot study.
    Gupta A; Chen HC; Rassam SM; Kohner EM
    Eye (Lond); 1994; 8 ( Pt 6)():668-71. PubMed ID: 7867825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of 0.5% timolol maleate on the ocular perfusion of ocular hypertensive patients by scanning laser flowmetry.
    Wang TH; Hung PT; Huang JK; Shih YF
    J Ocul Pharmacol Ther; 1997 Jun; 13(3):225-33. PubMed ID: 9185038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term effects of topical levobunolol on the human retinal circulation.
    Leung M; Grunwald JE
    Eye (Lond); 1997; 11 ( Pt 3)():371-6. PubMed ID: 9373479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].
    Höh H
    Fortschr Ophthalmol; 1988; 85(2):132-8. PubMed ID: 2899042
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of L-timolol, D-timolol, haloperidol and domperidone on rabbit retinal blood flow measured with laser Doppler method.
    Yan HY; Chiou GC
    Ophthalmic Res; 1987; 19(1):45-8. PubMed ID: 3299200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers.
    Gross RL; Hensley SH; Gao F; Wu SM
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S162-70. PubMed ID: 10416759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A long-term study of the visual fields in patients treated with betaxolol and timolol].
    Flammer J; Collignon-Brach J; Demailly P; Graves SA
    Oftalmologia; 1998; 42(1):77-82; discussion 82-3. PubMed ID: 9713206
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of 3 topically administered beta blockers on the rabbit crystalline lens].
    Eckerskorn U; Wegener A; Hockwin O; Fournes C; Ermisch S; Müller P; Möller B
    Fortschr Ophthalmol; 1988; 85(2):139-43. PubMed ID: 2899043
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of betaxolol on impaired choroidal blood flow after intravitreal injection of endothelin-1 in albino rabbits.
    Kim JH; Kim DM; Park WC
    J Ocul Pharmacol Ther; 2002 Jun; 18(3):203-9. PubMed ID: 12099541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does glaucoma medication influence the diameter of the retinal arteriole in the human eye? (A pilot study using the retinal vessel analyser).
    Kóthy P; Holló G
    Acta Physiol Hung; 2001; 88(3-4):281-92. PubMed ID: 12162586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells.
    van Beek LM; Mulder M; van Haeringen NJ; Kijlstra A
    Br J Ophthalmol; 2000 Sep; 84(9):1004-7. PubMed ID: 10966954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of beta-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells.
    Zhang J; Wu SM; Gross RL
    Brain Res; 2003 Jan; 959(1):111-9. PubMed ID: 12480164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
    Chidlow G; Melena J; Osborne NN
    Br J Pharmacol; 2000 Jun; 130(4):759-66. PubMed ID: 10864881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
    Le Jeunne C; Munera Y; Hugues FC
    Clin Pharmacol Ther; 1990 May; 47(5):578-83. PubMed ID: 1971539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct inhibition of N-methyl-D-aspartate (NMDA)-receptor function by antiglaucomatous beta-antagonists.
    Nagata T; Ueno S; Morita H; Kubota T; Toyohira Y; Tsutsui M; Tawara A; Yanagihara N
    J Pharmacol Sci; 2008 Mar; 106(3):423-34. PubMed ID: 18319565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of timolol, betaxolol, and placebo on corneal sensitivity in healthy volunteers.
    Vogel R; Clineschmidt CM; Hoeh H; Kulaga SF; Tipping RW
    J Ocul Pharmacol; 1990; 6(2):85-90. PubMed ID: 2394934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of timolol maleate on the retinal circulation of human eyes with ocular hypertension.
    Grunwald JE
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):521-6. PubMed ID: 2138590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasorelaxant effects of racemic betaxolol and its R- and S- isomers on bovine retinal vessels.
    Kulkarni PS; DeSantis L
    J Glaucoma; 2001 Oct; 10(5):423-6. PubMed ID: 11711842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.